Literature DB >> 17563882

Dexmedetomidine inhibits muscarinic type 3 receptors expressed in Xenopus oocytes and muscarine-induced intracellular Ca2+ elevation in cultured rat dorsal root ganglia cells.

Atsushi Takizuka1, Kouichiro Minami, Yasuhito Uezono, Takafumi Horishita, Toru Yokoyama, Munehiro Shiraishi, Takeshi Sakurai, Akio Shigematsu, Yoichi Ueta.   

Abstract

Dexmedetomidine, an alpha(2)-adrenoceptor agonist, has been approved for clinical use, although the mechanism of dexmedetomidine action has not been fully elucidated. Several studies have shown that G protein-coupled receptors (GPCRs) are recognized as targets for anesthetics and analgesics. Therefore, it is of interest to determine whether dexmedetomidine affects the function of GPCRs other than the alpha(2)-adrenoceptor. We examined the effects of dexmedetomidine on M(1), M(3), 5-HT(2C), substance P, and orexin 1 receptors in Xenopus oocytes expressing individual receptors. In addition, we investigated the effects of dexmedetomidine on muscarinic receptor-mediated changes in [Ca(2+)](i) in the dorsal root ganglia (DRG) of 3-week-old Wister rats. Dexmedetomidine did not affect the 5-HT(2C)-, or substance P-induced Cl(-) currents and had little inhibition on the orexin A-induced current in oocytes expressing the respective receptors. The compound also had little effect on the acetylcholine (ACh, 1 microM)-induced Ca(2+)-activated Cl(-) currents in Xenopus oocytes expressing M(1) receptors. In contrast, dexmedetomidine inhibited the ACh-induced currents in Xenopus oocytes expressing M(3) receptors; 1 nM, 10 nM, 100 nM, and 1 microM dexmedetomidine reduced the current to 66.5 +/- 4.8, 51.3 +/- 12, 34.6 +/- 11, and 26.8 +/- 6.4% of the control value, respectively (EC(50) = 3.5 +/- 0.7 nM). Dexmedetomidine reduced the ACh-induced Cl(-) currents after treatment with the selective protein kinase C inhibitor GF109203X. Moreover, the compound inhibited the muscarinic receptor-mediated increases in [Ca(2+)](i) in cultured DRG cells in a concentration-dependent manner. Dexmedetomidine inhibits the function of M(3) receptors, in addition to its agonistic effects on alpha(2)-adrenoceptors, which provides further insight into the pharmacological properties of dexmedetomidine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17563882     DOI: 10.1007/s00210-007-0168-4

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.195


  50 in total

1.  The effects of isoflurane on native and chimeric muscarinic acetylcholine receptors: the role of protein kinase C.

Authors:  S H Do; G L Kamatchi; M E Durieux
Journal:  Anesth Analg       Date:  2001-08       Impact factor: 5.108

2.  Muscarinic receptors modulate intracellular calcium level in chick sensory neurons.

Authors:  A M Tata; A Tripiciano; A Filippini; S Biagioni; G Augusti-Tocco
Journal:  Brain Res       Date:  2000-06-02       Impact factor: 3.252

Review 3.  Muscarinic receptors--characterization, coupling and function.

Authors:  M P Caulfield
Journal:  Pharmacol Ther       Date:  1993-06       Impact factor: 12.310

4.  Evidence that multiple P2X purinoceptors are functionally expressed in rat supraoptic neurones.

Authors:  I Shibuya; K Tanaka; Y Hattori; Y Uezono; N Harayama; J Noguchi; Y Ueta; F Izumi; H Yamashita
Journal:  J Physiol       Date:  1999-01-15       Impact factor: 5.182

5.  5-HT2 and 5-HT3 receptors mediate two distinct depolarizing responses in rat dorsal root ganglion neurons.

Authors:  S Todorović; E G Anderson
Journal:  Brain Res       Date:  1990-03-12       Impact factor: 3.252

6.  The effects of the neurosteroids: pregnenolone, progesterone and dehydroepiandrosterone on muscarinic receptor-induced responses in Xenopus oocytes expressing M1 and M3 receptors.

Authors:  Takafumi Horishita; Kouichiro Minami; Yasuhito Uezono; Munehiro Shiraishi; Junichi Ogata; Takashi Okamoto; Tadanori Terada; Takeyoshi Sata
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-03-19       Impact factor: 3.000

7.  Effects of anesthetics on the function of orexin-1 receptors expressed in Xenopus oocytes.

Authors:  Kouichiro Minami; Yasuhito Uezono; Takeshi Sakurai; Takafumi Horishita; Munehiro Shiraishi; Yoichi Ueta
Journal:  Pharmacology       Date:  2007-04-13       Impact factor: 2.547

8.  Effects of ethanol and anesthetics on type 1 and 5 metabotropic glutamate receptors expressed in Xenopus laevis oocytes.

Authors:  K Minami; R W Gereau; M Minami; S F Heinemann; R A Harris
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

Review 9.  Pharmacology of serotonin as related to anesthesia.

Authors:  L Gyermek
Journal:  J Clin Anesth       Date:  1996-08       Impact factor: 9.452

Review 10.  Molecular biology of serotonin receptors structure and function at the molecular level.

Authors:  Wesley K Kroeze; Kurt Kristiansen; Bryan L Roth
Journal:  Curr Top Med Chem       Date:  2002-06       Impact factor: 3.295

View more
  12 in total

1.  Intraoperative administration of dexmedetomidine reduced the postoperative catheter-related bladder discomfort and pain in patients undergoing lumbar microdiscectomy.

Authors:  Youngsuk Kwon; Ji Su Jang; Sung Mi Hwang; Jae Jun Lee; Hyonjin Tark
Journal:  J Anesth       Date:  2017-11-02       Impact factor: 2.078

Review 2.  The recent progress in research on effects of anesthetics and analgesics on G protein-coupled receptors.

Authors:  Kouichiro Minami; Yasuhito Uezono
Journal:  J Anesth       Date:  2012-10-26       Impact factor: 2.078

3.  Long-term anodal block stimulation at sacral anterior roots promoted recovery of neurogenic bladder function in a rabbit model of complete spinal cord injury.

Authors:  Xiaoran Wang; Qi Gao; Xiaoyu Yang; Weihua Wang; Xinquan Gu; Guifeng Liu; Peng Yan; Ge Gao; Xin Yu; Yongjie Wang; Jihu Lian; Chaoling Shi; Yao Wang; Li Fan
Journal:  Neural Regen Res       Date:  2012-02-15       Impact factor: 5.135

4.  Dexmedetomidine and fentanyl exhibit temperature dependent effects on human respiratory cilia.

Authors:  Nils Welchering; Sebastian Ochoa; Xin Tian; Richard Francis; Maliha Zahid; Ricardo Muñoz; Cecilia W Lo
Journal:  Front Pediatr       Date:  2015-02-11       Impact factor: 3.418

5.  The neuroprotective action of dexmedetomidine on apoptosis, calcium entry and oxidative stress in cerebral ischemia-induced rats: Contribution of TRPM2 and TRPV1 channels.

Authors:  Hatice Akpınar; Mustafa Nazıroğlu; İshak Suat Övey; Bilal Çiğ; Orhan Akpınar
Journal:  Sci Rep       Date:  2016-11-22       Impact factor: 4.379

6.  Comparison of intravenous lidocaine and dexmedetomidine infusion for prevention of postoperative catheter-related bladder discomfort: a randomized controlled trial.

Authors:  S Y Li; H Li; J Ni; Y S Ma
Journal:  BMC Anesthesiol       Date:  2019-03-18       Impact factor: 2.217

7.  Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling.

Authors:  Mei Yuan; Xiao-Wen Meng; Jiao Ma; Hong Liu; Shao-Yong Song; Qing-Cai Chen; Hua-Yue Liu; Juan Zhang; Nan Song; Fu-Hai Ji; Ke Peng
Journal:  Drug Des Devel Ther       Date:  2019-09-02       Impact factor: 4.162

8.  Dexmedetomidine Attenuates Neuropathic Pain by Inhibiting P2X7R Expression and ERK Phosphorylation in Rats.

Authors:  Jia-Piao Lin; Chao-Qin Chen; Ling-Er Huang; Na-Na Li; Yan Yang; Sheng-Mei Zhu; Yong-Xing Yao
Journal:  Exp Neurobiol       Date:  2018-08-30       Impact factor: 3.261

9.  Dexmedetomidine for prevention of early postoperative catheter-related bladder discomfort in voluntary kidney donors: Prospective, randomized, double-blind, placebo-controlled trial.

Authors:  Tapas Kumar Singh; Sandeep Sahu; Anil Agarwal; Devendra Gupta; Prabhaker Mishra
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2018 Apr-Jun

10.  Intravesical dexmedetomidine instillation reduces postoperative catheter-related bladder discomfort in male patients under general anesthesia: a randomized controlled study.

Authors:  Hong Chen; Bin Wang; Qin Li; Juan Zhou; Rui Li; Ye Zhang
Journal:  BMC Anesthesiol       Date:  2020-10-22       Impact factor: 2.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.